Nivalis Therapeutics, Inc. (NASDAQ:NVLS)

Nivalis Therapeutics, Inc. is a pharmaceutical company. The company is engaged in discovery, development and commercialization of molecule therapeutics for cystic fibrosis. Nivalis Therapeutics, Inc. is headquartered in Boulder, Colorado.

Nivalis Therapeutics, Inc. (NASDAQ:NVLS)’s Financial Overview

Nivalis Therapeutics, Inc. (NASDAQ:NVLS) declined -15.56% yesterday to close its trading session at $2.17. The company has 1 year Price Target of $23.75. Nivalis Therapeutics, Inc. has 52-Week high of $9.46 and 52-Week Low of $2.09. The stock touched its 52-Week High on Dec 22, 2015 and 52-Week Low on Nov 29, 2016. The stock traded with the volume of 1.85 Million shares yesterday. The firm shows the market capitalization of $33.72 Million.

Nivalis Therapeutics, Inc. (NASDAQ:NVLS) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $-0.48/share against the analyst consensus estimate of $-0.59/share. The difference between the actual and expected EPS is $0.11 a share with a surprise factor of 18.6%.

The firm is trading with SMA20 of -62.61 Percent, SMA50 of -68.38 Percent and SMA200 of -59.93 percent. Nivalis Therapeutics, Inc. has P/S value of 0 while its P/B value stands at 0.54. Similarly, the company has Return on Assets of -39 percent, Return on Equity of -41.7 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Nivalis Therapeutics, Inc. (NASDAQ:NVLS). On 29-Nov-16 Stifel Downgrade Nivalis Therapeutics, Inc. Stock  to Hold. Another firm also rated the stock on 29-Nov-16 where Raymond James Downgrade the stock to Mkt Perform.

The Stock currently has Analyst’ mean Recommendation of 1.6 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 3 analysts offering 12-month price forecasts for Nivalis Therapeutics Inc have a median target of 20.00, with a high estimate of 29.00 and a low estimate of 16.00. The median estimate represents a +821.66% increase from the last price of 2.17.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

STMicroelectronics NV (NYSE:STM)

STMicroelectronics is a global independent semiconductor company which designs, develops, manufactures and markets a broad range of semiconductor integrated circuits and discrete devices used in a wide variety of microelectronic applications, including telecommunications systems, computer systems, consumer products, automotive products and industrial automation and control systems.

STMicroelectronics NV (NYSE:STM)’s Financial Outlook

The 24 analysts offering 12-month price forecasts for STMicroelectronics NV have a median target of 8.68, with a high estimate of 13.05 and a low estimate of 5.14. The median estimate represents a -14.98% decrease from the last price of 10.21.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, STMicroelectronics NV has a Consensus Recommendation of 2. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock gained 3.55% and closed its last trading session at $10.21. The company has the market capitalization of $9.39 Billion. The stock has 52-week high of $10.26 and 52-Week low of $5.11. The firm touched its 52-Week high on Nov 30, 2016 and 52-Week low on Apr 6, 2016. The company has volume of 6.86 Million shares. The company has a total of 919.36 Million shares outstanding.

STMicroelectronics NV (NYSE:STM) in the last quarter reported its actual EPS of $0.11/share where the analyst estimated EPS was $0.11/share. The difference between the actual and Estimated EPS is $0. This shows a surprise factor of 0 percent.

The company has YTD performance of 58.88 percent. Beta for STMicroelectronics NV stands at 0.89 while its ATR (average true range) is 0.23. The company has Weekly Volatility of 1.42%% and Monthly Volatility of 1.83%%.

STMicroelectronics NV has distance from 20-day Simple Moving Average (SMA20) of 9.03%, Distance from 50-Day Simple Moving Average of 18.02 percent and Distance from 200-Day Simple Moving Average of 51.2%.

The Company currently has ROA (Return on Assets) of 0.7 percent, Return on Equity (ROE) of 1.2 Percent and Return on Investment (ROI) of 2.1% with Gross margin of 34.2 percent and Operating & Profit margin of 1.6% and 0.8% respectively.